The Medicines CompanyParsippany, NJ United States
Company Description
The Medicines Company will meet you at the hospital. The drug developer focuses on treatments used in acute care settings, including the ER, the surgical suite, and the cardiac catheterization lab. Its marketed products are Angiomax, an anticoagulant used during coronary angioplasties, and Cleviprex, an IV drug used to control blood pressure spikes. While it distributes the drugs through a third party, the company uses its own sales force to market the drugs to hospitals (mainly those with cardiac cath labs) in the US. The Medicines Company has four other compounds in various stages of development including cangrelor, an anti-platelet agent with possible use during cardiac catheterization, and antibiotic oritavancin.
| 8 Sylvan Way | Phone: 973-290-6000 | http://www.themedicinescompany.com |
| Parsippany, NJ 07054 | Fax: 973-656-9898 | |
| United States | Toll Free: 800-388-1183 |
The Medicines Company Rankings
| S&P 600 | Russell 2000 (June 2011) |
Executives
| 15 executives listed for The Medicines Company's Parsippany, NJ location. | ||
| Chairman, President, and CEO | Clive Meanwell | |
|---|---|---|
| EVP and CFO | Glenn Sblendorio | |
| VP New Business Ventures and Chief Medical Advisor | T. Scott Johnson | |
Financials
| Company Type | Public - NASDAQ: MDCO Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 421 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on The Medicines Company now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
